Ionis Pharmaceuticals IONS Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's other income (expense)?
- Ionis Pharmaceuticals (IONS) reported other income (expense) of -$456K in Q1 2026.
- How has Ionis Pharmaceuticals's other income (expense) changed year-over-year?
- Ionis Pharmaceuticals's other income (expense) decreased by 198.1% year-over-year, from $465K to -$456K.
- What is the long-term trend for Ionis Pharmaceuticals's other income (expense)?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's other income (expense) has grown at a 12.0% compound annual growth rate (CAGR), from -$9.76M to -$15.36M.
- What does other income (expense) mean?
- Net gains or losses from activities not related to core business operations.
- How do you interpret other income (expense)?
- Large fluctuations here can distort net income, requiring investors to look at core operating performance separately.
- How does other income (expense) compare across companies?
- Highly variable across companies depending on asset divestitures and currency exposure.